medigraphic.com
SPANISH

Revista Latinoamericana de Infectología Pediátrica

ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

Rev Latin Infect Pediatr 2019; 32 (3)

Human herpes virus -7 in pediatrics

González SN, Aguilar GNE, Rivera MER, Hernández CCA
Full text How to cite this article

Language: Spanish
References: 23
Page: 109-112
PDF size: 176.62 Kb.


Key words:

Human herpesvirus 7, pediatrics.

ABSTRACT

Human herpesvirus-7 (HHV-7) is a ubiquitous virus that belongs to the subfamily of β-herpesviruses (together with cytomegalovirus and human herpesvirus-6). Primary HHV-7 infection usually occurs during childhood and may cause several clinical manifestations: mainly exanthem subitum (roseola infantum), followed by a lifelong latent state with possible reactivation in case of immunodeficiency. Considering what is mentioned above, we decided to present a systematic review of the clinical manifestation of HHV-7 in the pediatric population.


REFERENCES

  1. Frenkel N, Schirmer E, Wyatt L et al. Isolation of a new herpesvirus from CD4+ T cells. Proc Natl Acad Sci USA. 1990; 87: 748-752.

  2. Sadayoshi T, Kumamoto T, Koide W. Clinical manifestation associated with humanherpes virus 7 infection. Archives of Disease in Childhood. 1995; 72: 518-519.

  3. Dewhurst S, Skrincosky D, Van Loon N. Human herpesvirus 7. Expert Reviews in Molecular Medicine. 1997; 1-12.

  4. Ablashi D, Berneman Z, Kramarsky B. Human herpesvirus- 7 (HHV-7): current status. Clinical Diagnostic Virology. 1995; (4): 1-13.

  5. Bruns R, Muller C, Wiersbitzky W. Clinical presentation of infection by the human herpesvirus-7. Pediatric Hematology and Oncology. 2000; 17: 247-252.

  6. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol. 2005; 32: 183-199.

  7. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013; 13 (suppl 3): 67-77.

  8. Krueger GR et al. Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countries. Vox Sang. 1998; 75 (3): 193-197.

  9. Fujisaki H, Tanaka-Taya K, Tanabe H, Hara T, Miyoshi H, Okada S et al. Detection of human herpesvirus 7 (HHV-7) DNA in breast milk by polymerase chain reaction and prevalence of HHV-7 antibody in breast-fed and bottle-fed children. J Med Virol. 1998; 56 (3): 275.

  10. Okuno T, Oishi H, Hayashi K et al. Human herpesviruses 6 and 7 in cervixes of pregnant women. J Clin Microbiol. 1995; 33: 1968-1970.

  11. Dockrell DH, Paya CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol. 2001; 11: 23-36.

  12. Chan PKS, Li CK, Chik KW et al. Risk factors and clinical consequences of human herpesvirus 7 infection in pediatric hematopoietic stem cell transplant recipients. J Med Virol. 2004; 72: 668-674.

  13. Hall CB, Caserta MT, Schnabel KC et al. Characteristics and acquisition of human herpesvirus (HHV) 7 infections in relation to infection with HHV-6. J Infect Dis. 2006; 193: 1063-1069.

  14. Ward KN, Andrews NJ, Verity CM et al. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child. 2005; 90: 619-623.

  15. Chan PK, Ng HK, Hui M, Ip M, Cheung JL, Cheng AF. Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue. J Med Virol. 1999; 59 (4): 491-495.

  16. Chan PK, Ng HK, Cheung JL, Ng KC, Cheng AF. Prevalence and distribution of human herpesvirus 7 in normal brain. J Med Virol. 2000; 62 (3): 345-348.

  17. Humg L, Lee C, Liu M. Primary infections of human herpesvirus-7 and herpesvirus-6: a comparative, longitudinal study up to 6 years of age, Acta Paediatr. 1997; 86: 604-608.

  18. Ward K, Andrew J, Verity M. Human herpesviruses-6 and 7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child. 2005; 90: 619-623.

  19. Wolz M, Gabriel F, Pittelkow M. Human herpesvirus 6, 7 and 8 from a dermatologic perspective. Mayo Clin Proc. 2012; 87 (10): 1004-1014.

  20. Schwartz K, Richardson S, Ward K. Delayed primary HHV-7 infection and neurologic disease. Pediatrics. 2014; 133: e1541-e1547.

  21. Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol. 2010; 28: 497-501.

  22. Venâncio P, João M, Pereira G. Anti-N-methyl-D-aspartate Receptor Encephalitis with Positive Serum Antithyroid Antibodies, IgM Antibodies Against Mycoplasma pneumoniae and Human Herpesvirus 7 PCR in the CSF The Pediatric Infectious Disease Journal. 2014; 33 (8): 50-58.

  23. Dalmau J, Lancaster E, Martinez E. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10: 63-74.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Latin Infect Pediatr. 2019;32